Literature DB >> 765499

Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma.

E J Sanford, J R Drago, T J Rohner, R Santen, A Lipton.   

Abstract

Complete adrenal suppression with aminoglutethimide has been accomplished in 7 patients with progressive stage D carcinoma of the prostate who had become refractory to orchiectomy and the administration of exogenous estrogens. A favorable response was noted in 3 patients. These preliminary results indicate that this agent may be as useful as surgical adrenalectomy in the treatment of progressive prostatic carcinoma. A brief discussion of the pharmacology of this agent, its mode of administration and the side effects are presented.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 765499     DOI: 10.1016/s0022-5347(17)59121-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  A history of prostate cancer treatment.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

2.  A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.

Authors:  D L Trump; J C Marsh; L K Kvols; D Citrin; T E Davis; R G Hahn; S E Vogl
Journal:  Invest New Drugs       Date:  1990       Impact factor: 3.850

Review 3.  Hormonal aspects of prostatic cancer: a review.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1985-02       Impact factor: 5.344

Review 4.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 5.  Aromatase inhibitors in malignant diseases of aging.

Authors:  D C Johannessen; P E Lønning
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 6.  Drug therapy of prostatic cancer.

Authors:  R P Huben; S D Perrapato
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 7.  Precision medicine applications in prostate cancer.

Authors:  Edel M McCrea; Daniel K Lee; Tristan M Sissung; William D Figg
Journal:  Ther Adv Med Oncol       Date:  2018-06-18       Impact factor: 8.168

8.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.